# Sanofi opens new influenza vaccine manufacturing facility in Swiftwater, Pennsylvania

Sanofi received FDA approval for an additional influenza manufacturing facility in Swiftwater, PA, expanding production of Fluzone High-Dose Quadrivalent. The $425 million investment will create up to 200 jobs.

- Type: Expansion
- Announced: 2021-06-17
- Where: Swiftwater, Pennsylvania, United States
- Value: $425.0M
- Jobs: 200
- Starts operating: 17 Jun 2021
- Status: completed
- Products: Fluzone High-Dose Quadrivalent influenza vaccine
- Sectors: [Medical Devices](https://endata.com/sectors/medical-devices.md)

## Companies

- [Sanofi](https://endata.com/companies/10465.md)

## Sources

- [news.sanofi.us](https://www.news.sanofi.us/2021-06-17-Newly-licensed-US-manufacturing-facility-to-increase-availability-of-Fluzone-R-High-Dose-Quadrivalent-influenza-vaccine), 2021-06-17: "Our new facility will complement our existing capacities to produce enough high-dose vaccine for all people 65 and older in as many countries as possible this flu season and beyond."

---
Data from Endata (https://endata.com/). Announcements are summarized from public sources and may be incomplete; check the linked originals.